相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Melatonin attenuates osteosarcoma cell invasion by suppression of C-C motif chemokine ligand 24 through inhibition of the c-Jun N-terminal kinase pathway
Ko-Hsiu Lu et al.
JOURNAL OF PINEAL RESEARCH (2018)
Hispolon suppresses migration and invasion of human nasopharyngeal carcinoma cells by inhibiting the urokinase-plasminogen activator through modulation of the Akt signaling pathway
Hsin-Yu Ho et al.
ENVIRONMENTAL TOXICOLOGY (2017)
Cancer metastasis: Mechanisms of inhibition by melatonin
Shih-Chi Su et al.
JOURNAL OF PINEAL RESEARCH (2017)
Tricetin suppresses human oral cancer cell migration by reducing matrix metalloproteinase-9 expression through the mitogen-activated protein kinase signaling pathway
Tsung-Te Chung et al.
ENVIRONMENTAL TOXICOLOGY (2017)
Duchesnea indica extract suppresses the migration of human lung adenocarcinoma cells by inhibiting epithelial-mesenchymal transition
Pei-Ni Chen et al.
ENVIRONMENTAL TOXICOLOGY (2017)
Dihydromyricetin-mediated inhibition of the Notch1 pathway induces apoptosis in QGY7701 and HepG2 hepatoma cells
Cai-Jie Lu et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2017)
Hispolon suppresses metastasis via autophagic degradation of cathepsin S in cervical cancer cells
Min-Chieh Hsin et al.
CELL DEATH & DISEASE (2017)
Overexpression of carbonic anhydrase IX induces cell motility by activating matrix metalloproteinase-9 in human oral squamous cell carcinoma cells
Jia-Sin Yang et al.
ONCOTARGET (2017)
Inhibition of cathepsin S confers sensitivity to methyl protodioscin in oral cancer cells via activation of p38 MAPK/JNK signaling pathways
Ming-Ju Hsieh et al.
SCIENTIFIC REPORTS (2017)
The urokinase-type plasminogen activator (uPA) system as a biomarker and therapeutic target in human malignancies
Shih-Chi Su et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2016)
Lipocalin 2 prevents oral cancer metastasis through carbonic anhydrase IX inhibition and is associated with favourable prognosis
Chiao-Wen Lin et al.
CARCINOGENESIS (2016)
Pharmacodynamic considerations in the use of matrix metalloproteinase inhibitors in cancer treatment
Jia-Sin Yang et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2016)
Melatonin suppresses TPA-induced metastasis by downregulating matrix metalloproteinase-9 expression through JNK/SP-1 signaling in nasopharyngeal carcinoma
Hsin-Yu Ho et al.
JOURNAL OF PINEAL RESEARCH (2016)
Tricetin suppresses the migration/invasion of human glioblastoma multiforme cells by inhibiting matrix metalloproteinase-2 through modulation of the expression and transcriptional activity of specificity protein 1
Rockey Chao et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2015)
Suppression of Inflammatory Responses by Dihydromyricetin, a Flavonoid from Ampelopsis grossedentata, via Inhibiting the Activation of NF-κB and MAPK Signaling Pathways
X. L. Hou et al.
JOURNAL OF NATURAL PRODUCTS (2015)
Dihydromyricetin protects endothelial cells from hydrogen peroxide-induced oxidative stress damage by regulating mitochondrial pathways
Xiaolong Hou et al.
LIFE SCIENCES (2015)
CLINICAL MANAGEMENT OF PROLIFERATIVE VITREORETINOPATHY An Update
Mohammed A. Khan et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2015)
Upregulation of miR-328 and inhibition of CREB-DNA-binding activity are critical for resveratrol-mediated suppression of matrix metalloproteinase-2 and subsequent metastatic ability in human osteosarcomas
Shun-Fa Yang et al.
ONCOTARGET (2015)
Resveratrol suppresses TPA-induced matrix metalloproteinase-9 expression through the inhibition of MAPK pathways in oral cancer cells
Feng-Yan Lin et al.
JOURNAL OF ORAL PATHOLOGY & MEDICINE (2015)
Remodelling the extracellular matrix in development and disease
Caroline Bonnans et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2014)
Dihydromyricetin inhibits migration and invasion of hepatoma cells through regulation of MMP-9 expression
Qing-Yu Zhang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Dihydromyricetin induces apoptosis and inhibits proliferation in hepatocellular carcinoma cells
Jie Liu et al.
ONCOLOGY LETTERS (2014)
Dihydromyricetin promotes hepatocellular carcinoma regression via a p53 activation-dependent mechanism
Qingyu Zhang et al.
SCIENTIFIC REPORTS (2014)
Matrix metalloproteinase-2 as a target for head and neck cancer therapy
Ming-Hsien Chien et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2013)
Interleukin-6 and matrix metalloproteinase expression in the subretinal fluid during proliferative vitreoretinopathy: Correlation with extent, duration of RRD and PVR grade
Chrysanthos Symeonidis et al.
CYTOKINE (2012)
Ampelopsin reduces endotoxic inflammation via repressing ROS-mediated activation of PI3K/Akt/NF-kappa B signaling pathways
Shimei Qi et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2012)
Elucidation of the Pathogenic Mechanism of Rhegmatogenous Retinal Detachment with Proliferative Vitreoretinopathy by Proteomic Analysis
Jing Yu et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2012)
Correlation of matrix metalloproteinase levels with the grade of proliferative vitreoretinopathy in the subretinal fluid and vitreous during rhegmatogenous retinal detachment
Chrysanthos Symeonidis et al.
ACTA OPHTHALMOLOGICA (2011)
Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting
Chrisostomi Gialeli et al.
FEBS JOURNAL (2011)
Correlation of the extent and duration of rhegmatogenous, retinal detachment with the expression of matrix metalloproteinases in the vitreous
Chrysanthos Symeonidis et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2007)
MMP-2 plays an essential role in producing epithelial-mesenchymal transformations in the avian embryo
TD Duong et al.
DEVELOPMENTAL DYNAMICS (2004)
Effect of growth factors on bovine retinal pigment epithelial cell migration and proliferation
CW Spraul et al.
OPHTHALMIC RESEARCH (2004)
Drusen are cold spots for proteolysis: Expression of matrix metalloproteinases and their tissue inhibitor proteins in age-related macular degeneration
ST Leu et al.
EXPERIMENTAL EYE RESEARCH (2002)
Membrane type 1 matrix metalloproteinase and gelatinase A synergistically degrade type 1 collagen in a cell model
SJ Atkinson et al.
FEBS LETTERS (2001)